🌍September 29, 2026·13h agoResearchTier 1 · Research record

<scp>BEACON</scp> : An Adaptive Bayesian Early‐Phase Oncology Trial Design Integrating Dose Optimization and Proof‐of‐Concept Across Survival and Binary Endpoints

Publisher

Crossref

Global

This page provides publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.

Read original

At a glance

Publisher: Crossref
Region: Global
Scope: Research
Published: September 29, 2026
Language: EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on doi.org

Leave the platform to read the original full article on the publisher site.

Source: Crossref

Scope: Research

Evidence: Tier 1 · Research record

Open original article

Related coverage

More related coverage

Universitätsspital Zürich (USZ)/4h ago

Drei Leuchtturmprojekte für präzisere Therapien

Hospital Clínic de Barcelona/5h ago

The HCB-IDIBAPS Biobank has obtained ISO 20387 accreditation, the leading international standard of excellence and quality

UNMC/6h ago

Universidad Anahuac leaders visit UNMC